Literature DB >> 26727658

Eosinophilic Esophagitis-Associated Chemical and Mechanical Microenvironment Shapes Esophageal Fibroblast Behavior.

Amanda B Muir1, Kara Dods, Steven J Henry, Alain J Benitez, Dale Lee, Kelly A Whelan, Maureen DeMarshall, Daniel A Hammer, Gary Falk, Rebecca G Wells, Jonathan Spergel, Hiroshi Nakagawa, Mei-Lun Wang.   

Abstract

OBJECTIVES: Eosinophilic esophagitis (EoE) is an immune-mediated allergic disease characterized by progressive esophageal dysmotility and fibrotic stricture associated with chronic esophageal fibroblast activation. It remains unknown how esophageal fibroblasts respond to EoE-relevant matrix stiffness or inflammatory cytokines.
METHODS: Immunofluorescence was used to evaluate α-smooth muscle actin (α-SMA) expression in endoscopic esophageal biopsies. Primary esophageal fibroblasts from adult and pediatric patients with or without EoE were exposed to transforming growth factor (TGF)β to determine gene expression, collagen-matrix contractility, and cytoskeletal organization. The influence of matrix stiffness upon fibroblast behavior was assessed on the engineered surface of polyacrylamide gels with varying stiffness. Fibroblast traction forces were measured using microfabricated-post-array-detectors.
RESULTS: EoE esophageal fibroblasts had enhanced α-SMA expression. TGFβ not only stimulated enhanced fibroblast-specific gene expression but also promoted fibroblast-mediated collagen-matrix contraction, despite disease state or age of patients as the origin of cells. Unlike conventional monolayer cell, culture conditions using plastic surface (1 GPa) that activates fibroblasts constitutively, our engineered platforms recapitulating physiologically relevant stiffness (1-20 kPa) revealed that matrix stiffness defines the extent of α-SMA expression, intracellular collagen fibril organization, SMAD3 phosphorylation, and fibroblast traction force.
CONCLUSIONS: Matrix stiffness may critically influence TGFβ-mediated gene expression and functions of esophageal fibroblasts ex vivo independent of age and disease conditions. These findings provide a novel insight into the pathogenesis of fibrostenotic disease in EoE.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26727658      PMCID: PMC4929044          DOI: 10.1097/MPG.0000000000001100

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  38 in total

Review 1.  Systematic review with meta-analysis: pharmacological interventions for eosinophilic oesophagitis.

Authors:  T Sawas; S Dhalla; M Sayyar; P J Pasricha; R Hernaez
Journal:  Aliment Pharmacol Ther       Date:  2015-03-01       Impact factor: 8.171

2.  Manometric features of eosinophilic esophagitis in esophageal pressure topography.

Authors:  S Roman; I Hirano; M A Kwiatek; N Gonsalves; J Chen; P J Kahrilas; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2010-11-23       Impact factor: 3.598

3.  Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study.

Authors:  Alfredo J Lucendo; Angel Arias; Livia C De Rezende; Jose Luis Yagüe-Compadre; Teresa Mota-Huertas; Sonia González-Castillo; Rubén A Cuesta; José M Tenias; Teresa Bellón
Journal:  J Allergy Clin Immunol       Date:  2011-08-30       Impact factor: 10.793

Review 4.  Fetal skin possesses the ability to regenerate completely: complete regeneration of skin.

Authors:  Kazuo Kishi; Keisuke Okabe; Ruka Shimizu; Yoshiaki Kubota
Journal:  Keio J Med       Date:  2012

5.  Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response.

Authors:  G S Ashcroft; X Yang; A B Glick; M Weinstein; J L Letterio; D E Mizel; M Anzano; T Greenwell-Wild; S M Wahl; C Deng; A B Roberts
Journal:  Nat Cell Biol       Date:  1999-09       Impact factor: 28.824

Review 6.  Tissue remodeling in eosinophilic esophagitis.

Authors:  Edaire Cheng; Rhonda F Souza; Stuart J Spechler
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-09-27       Impact factor: 4.052

Review 7.  Eosinophilic esophagitis: updated consensus recommendations for children and adults.

Authors:  Chris A Liacouras; Glenn T Furuta; Ikuo Hirano; Dan Atkins; Stephen E Attwood; Peter A Bonis; A Wesley Burks; Mirna Chehade; Margaret H Collins; Evan S Dellon; Ranjan Dohil; Gary W Falk; Nirmala Gonsalves; Sandeep K Gupta; David A Katzka; Alfredo J Lucendo; Jonathan E Markowitz; Richard J Noel; Robert D Odze; Philip E Putnam; Joel E Richter; Yvonne Romero; Eduardo Ruchelli; Hugh A Sampson; Alain Schoepfer; Nicholas J Shaheen; Scott H Sicherer; Stuart Spechler; Jonathan M Spergel; Alex Straumann; Barry K Wershil; Marc E Rothenberg; Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2011-04-07       Impact factor: 10.793

8.  Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis.

Authors:  Mario Noti; Elia D Tait Wojno; Brian S Kim; Mark C Siracusa; Paul R Giacomin; Meera G Nair; Alain J Benitez; Kathryn R Ruymann; Amanda B Muir; David A Hill; Kudakwashe R Chikwava; Amin E Moghaddam; Quentin J Sattentau; Aneesh Alex; Chao Zhou; Jennifer H Yearley; Paul Menard-Katcher; Masato Kubo; Kazushige Obata-Ninomiya; Hajime Karasuyama; Michael R Comeau; Terri Brown-Whitehorn; Rene de Waal Malefyt; Patrick M Sleiman; Hakon Hakonarson; Antonella Cianferoni; Gary W Falk; Mei-Lun Wang; Jonathan M Spergel; David Artis
Journal:  Nat Med       Date:  2013-07-21       Impact factor: 53.440

9.  Immunohistochemical localization of growth factors in fetal wound healing.

Authors:  D J Whitby; M W Ferguson
Journal:  Dev Biol       Date:  1991-09       Impact factor: 3.582

10.  The extracellular matrix of lip wounds in fetal, neonatal and adult mice.

Authors:  D J Whitby; M W Ferguson
Journal:  Development       Date:  1991-06       Impact factor: 6.868

View more
  15 in total

Review 1.  Biological therapies for eosinophilic gastrointestinal diseases.

Authors:  Joshua B Wechsler; Ikuo Hirano
Journal:  J Allergy Clin Immunol       Date:  2018-05-31       Impact factor: 10.793

Review 2.  Pathophysiology of Eosinophilic Esophagitis.

Authors:  Kelly M O'Shea; Seema S Aceves; Evan S Dellon; Sandeep K Gupta; Jonathan M Spergel; Glenn T Furuta; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2017-07-27       Impact factor: 22.682

3.  New developments in patients with eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERS Symposium at the 2018 American Academy of Allergy, Asthma & Immunology Meeting.

Authors:  Jonathan M Spergel; Seema S Aceves; Kara Kliewer; Nirmala Gonsalves; Mirna Chehade; Joshua B Wechsler; Marion Groetch; Joshua Friedlander; Evan S Dellon; Wendy Book; Ikuo Hirano; Amanda B Muir; Antonella Cianferoni; Lisa Spencer; Chris A Liacouras; Edaire Cheng; Leah Kottyan; Ting Wen; Thomas Platts-Mills; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2018-05-24       Impact factor: 10.793

Review 4.  EoE disease monitoring: Where we are and where we are going.

Authors:  Bridget Godwin; Benjamin Wilkins; Amanda B Muir
Journal:  Ann Allergy Asthma Immunol       Date:  2019-12-09       Impact factor: 6.347

5.  Fibrostenotic eosinophilic esophagitis might reflect epithelial lysyl oxidase induction by fibroblast-derived TNF-α.

Authors:  Yuta Kasagi; Kara Dods; Joshua X Wang; Prasanna M Chandramouleeswaran; Alain J Benitez; Fiona Gambanga; Jonathan Kluger; Tokunbo Ashorobi; Jonathan Gross; John W Tobias; Andres J Klein-Szanto; Jonathan M Spergel; Antonella Cianferoni; Gary W Falk; Kelly A Whelan; Hiroshi Nakagawa; Amanda B Muir
Journal:  J Allergy Clin Immunol       Date:  2018-12-20       Impact factor: 14.290

6.  A unique esophageal extracellular matrix proteome alters normal fibroblast function in severe eosinophilic esophagitis.

Authors:  Lance Y Hsieh; Austin W T Chiang; Loan D Duong; Chih-Chung Kuo; Stephanie X Dong; Ranjan Dohil; Richard Kurten; Nathan E Lewis; Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2021-02-06       Impact factor: 14.290

7.  TGF-β1 alters esophageal epithelial barrier function by attenuation of claudin-7 in eosinophilic esophagitis.

Authors:  N Nguyen; S D Fernando; K A Biette; J A Hammer; K E Capocelli; D A Kitzenberg; L E Glover; S P Colgan; G T Furuta; J C Masterson
Journal:  Mucosal Immunol       Date:  2017-08-23       Impact factor: 7.313

Review 8.  Tissue Remodeling in Chronic Eosinophilic Esophageal Inflammation: Parallels in Asthma and Therapeutic Perspectives.

Authors:  Quan M Nhu; Seema S Aceves
Journal:  Front Med (Lausanne)       Date:  2017-08-07

9.  Persistent Basal Cell Hyperplasia Is Associated With Clinical and Endoscopic Findings in Patients With Histologically Inactive Eosinophilic Esophagitis.

Authors:  Kelly A Whelan; Bridget C Godwin; Benjamin Wilkins; Okan U Elci; Alain Benitez; Maureen DeMarshall; Medha Sharma; Jonathan Gross; Andres J Klein-Szanto; Chris A Liacouras; Evan S Dellon; Jonathan M Spergel; Gary W Falk; Amanda B Muir; Hiroshi Nakagawa
Journal:  Clin Gastroenterol Hepatol       Date:  2019-09-06       Impact factor: 11.382

10.  Creating a multi-center rare disease consortium - the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).

Authors:  Katherine Cheng; Sandeep K Gupta; Susanna Kantor; Jonathan T Kuhl; Seema S Aceves; Peter A Bonis; Kelley E Capocelli; Christina Carpenter; Mirna Chehade; Margaret H Collins; Evan S Dellon; Gary W Falk; Rashmi Gopal-Srivastava; Nirmala Gonsalves; Ikuo Hirano; Eileen C King; John Leung; Jeffrey P Krischer; Vincent A Mukkada; Alain Schoepfer; Jonathan M Spergel; Alex Straumann; Guang-Yu Yang; Glenn T Furuta; Marc E Rothenberg
Journal:  Transl Sci Rare Dis       Date:  2017-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.